0001493152-24-028186.txt : 20240717
0001493152-24-028186.hdr.sgml : 20240717
20240717163015
ACCESSION NUMBER: 0001493152-24-028186
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240715
FILED AS OF DATE: 20240717
DATE AS OF CHANGE: 20240717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Margrave David R.
CENTRAL INDEX KEY: 0001813162
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39318
FILM NUMBER: 241122589
MAIL ADDRESS:
STREET 1: 1920 MCKINNEY AVENUE, 7TH FLOOR
CITY: DALLAS
STATE: TX
ZIP: 75201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lantern Pharma Inc.
CENTRAL INDEX KEY: 0001763950
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 463973463
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1920 MCKINNEY AVENUE
STREET 2: 7TH FLOOR
CITY: DALLAS
STATE: TX
ZIP: 75201
BUSINESS PHONE: 972-277-1136
MAIL ADDRESS:
STREET 1: 1920 MCKINNEY AVENUE
STREET 2: 7TH FLOOR
CITY: DALLAS
STATE: TX
ZIP: 75201
FORMER COMPANY:
FORMER CONFORMED NAME: Lantern Pharma
DATE OF NAME CHANGE: 20190108
4
1
ownership.xml
X0508
4
2024-07-15
0
0001763950
Lantern Pharma Inc.
LTRN
0001813162
Margrave David R.
1920 MCKINNEY AVENUE, 7TH FLOOR
DALLAS
TX
75201
0
1
0
0
Chief Financial Officer
0
Stock Option (Right to Buy)
4.35
2024-07-15
4
A
0
52000
0.00
A
2034-07-15
Common Stock
52000
52000
D
The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing August 15, 2024.
/s/ David R. Margrave
2024-07-17